Eric A Weaver, PhD

Assistant Professor

  • 1342 Citations
  • 19 h-Index
20002019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Eric A Weaver is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Adenoviridae Medicine & Life Sciences
Vaccines Medicine & Life Sciences
Adenovirus Vaccines Medicine & Life Sciences
Viruses Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
Vaccination Medicine & Life Sciences
vaccines Agriculture & Biology
Feline Immunodeficiency Virus Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

  • 1342 Citations
  • 19 h-Index
  • 40 Article
  • 4 Review article
  • 1 Chapter

A review of 65 years of human adenovirus seroprevalence

Mennechet, F. J. D., Paris, O., Ouoba, A. R., Salazar Arenas, S., Sirima, S. B., Takoudjou Dzomo, G. R., Diarra, A., Traore, I. T., Kania, D., Eichholz, K., Weaver, E. A., Tuaillon, E. & Kremer, E. J., Jun 3 2019, In : Expert Review of Vaccines. 18, 6, p. 597-613 17 p.

Research output: Contribution to journalReview article

Human Adenoviruses
Seroepidemiologic Studies
Adenovirus Vaccines
Safety
Expert Testimony

A single-cycle adenovirus type 7 vaccine for prevention of acute respiratory disease

Bullard, B. L., Corder, B. N. & Weaver, E. A., May 2019, In : Viruses. 11, 5, 413.

Research output: Contribution to journalArticle

Open Access
Adenovirus Vaccines
Acute Disease
Viruses
Adenoviridae
Adenoviridae Infections
1 Citation (Scopus)

Longitudinal quantification of adenovirus neutralizing responses in Zambian mother-infant pairs: Impact of HIV-1 infection and its treatment

Privatt, S. R., Bullard, B. L., Weaver, E. A., Wood, C. & West, J. T., Aug 23 2019, In : Vaccine. 37, 36, p. 5177-5184 8 p.

Research output: Contribution to journalArticle

Adenoviridae
Human immunodeficiency virus 1
neutralization
HIV Infections
HIV-1

The Vaccinia Virus (VACV) B1 and cellular VRK2 kinases promote VACV replication factory formation through phosphorylation-dependent inhibition of VACV B12

Rico, A. B., Wang, Z., Olson, A. T., Linville, A. C., Bullard, B. L., Weaver, E. A., Jones, C. & Wiebe, M. S., Oct 1 2019, In : Journal of virology. 93, 20, e00855-19.

Research output: Contribution to journalArticle

Vaccinia virus
Virus Replication
virus replication
factories
phosphorylation
6 Citations (Scopus)

Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine

Bullard, B. L., Corder, B. N., Gorman, M. J., Diamond, M. S. & Weaver, E. A., Dec 1 2018, In : Scientific reports. 8, 1, 18017.

Research output: Contribution to journalArticle

Adenoviridae
Vaccines
T-Lymphocytes
Vaccination
Antibodies